*Sale of future Aphexda royalties
#$BLRX retains rights to future commercial milestone payments
*Proceeds will support GLIX1 development & partial loan repayment to Blackrock
*30Nov close
finance.yahoo.com/healthcare/a...
*Sale of future Aphexda royalties
#$BLRX retains rights to future commercial milestone payments
*Proceeds will support GLIX1 development & partial loan repayment to Blackrock
*30Nov close
finance.yahoo.com/healthcare/a...
https://www.stocktitan.net/news/BLRX/bio-line-rx-enters-into-5-6-million-royalty-monetization-transaction-98sthnofcjo8.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/BLRX/bio-line-rx-enters-into-5-6-million-royalty-monetization-transaction-98sthnofcjo8.html?utm_source=stocktitan-bluesky&utm_medium=social
*Call @ 8:30 am ET
*GLIX1 in GBM Ph1/2a ongoing
*Aphexda royalty revenue of $0.3mm
#$BLRX
ir.biolinerx.com/news-release...
*Call @ 8:30 am ET
*GLIX1 in GBM Ph1/2a ongoing
*Aphexda royalty revenue of $0.3mm
#$BLRX
ir.biolinerx.com/news-release...
*call @ 8:30 am ET
#$BLRX
We'll be looking for Aphexda sales trends, GLIX1 updates & status of global partnerships including the Ph2b PDAC trial with Columbia University
finance.yahoo.com/healthcare/a...
*call @ 8:30 am ET
#$BLRX
We'll be looking for Aphexda sales trends, GLIX1 updates & status of global partnerships including the Ph2b PDAC trial with Columbia University
finance.yahoo.com/healthcare/a...
*new asset search continues
*Aphexda generated $0.3mm license revenue
*31May ASCO PDAC presentation
$BLRX
ir.biolinerx.com/news-release...
*new asset search continues
*Aphexda generated $0.3mm license revenue
*31May ASCO PDAC presentation
$BLRX
ir.biolinerx.com/news-release...
prismmarketview.com/biolinerx-hi...
prismmarketview.com/biolinerx-hi...
#StockMarket #News
https://www.stocktitan.net/news/BLRX/bio-line-rx-reports-first-quarter-2026-financial-results-and-6tzwte2sv35a.html
https://www.stocktitan.net/news/BLRX/bio-line-rx-reports-first-quarter-2026-financial-results-and-6tzwte2sv35a.html
https://www.stocktitan.net/news/BLRX/bio-line-rx-and-ayrmid-ltd-enter-into-exclusive-license-agreement-to-zu9edtosljhn.html
https://www.stocktitan.net/news/BLRX/bio-line-rx-and-ayrmid-ltd-enter-into-exclusive-license-agreement-to-zu9edtosljhn.html